Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Expression Profile of Mycobacterium leprae Contribution in the Pathology of Leprosy Neuropathy. | Front Med (Lausanne) | 2022 | 35492305 | PubTator, text mining | PubMed |
| NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism. | BMC Genomics | 2022 | 35488210 | PubTator, text mining | PubMed |
| Biomaterials to enhance stem cell transplantation. | Cell Stem Cell | 2022 | 35483364 | PubTator, text mining | PubMed |
| Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment. | Science | 2022 | 35482859 | PubTator, text mining | PubMed |
| EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma. | Nat Commun | 2022 | 35477713 | PubTator, text mining | PubMed |
| Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review. | Bosn J Basic Med Sci | 2022 | 35465855 | PubTator, text mining | PubMed |
| ABCB6 knockdown suppresses melanogenesis through the GSK3-β/β-catenin signaling axis in human melanoma and melanocyte cell lines. | J Dermatol Sci | 2022 | 35461746 | PubTator, text mining | PubMed |
| Recent Advances in the Antiproliferative and Proapoptotic Activity of Various Plant Extracts and Constituents against Murine Malignant Melanoma. | Molecules | 2022 | 35458783 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study. | Int J Mol Sci | 2022 | 35457050 | PubTator, text mining | PubMed |
| Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase. | Int J Mol Sci | 2022 | 35456994 | PubTator, text mining | PubMed |
| Anti-Melanogenic and Antioxidant Effects of Cell-Free Supernatant from Lactobacillus gasseri BNR17. | Microorganisms | 2022 | 35456838 | PubTator, text mining | PubMed |
| CD47-SIRPα Checkpoint Disruption in Metastases Requires Tumor-Targeting Antibody for Molecular and Engineered Macrophage Therapies. | Cancers (Basel) | 2022 | 35454837 | PubTator, text mining | PubMed |
| The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma. | Biomedicines | 2022 | 35453572 | PubTator, text mining | PubMed |
| Antibiotic Resistance of Salmonella Typhimurium Monophasic Variant 1,4,[5],12:i:-in China: A Systematic Review and Meta-Analysis. | Antibiotics (Basel) | 2022 | 35453283 | PubTator, text mining | PubMed |
| Preferential stimulation of melanocytes by M2 macrophages to produce melanin through vascular endothelial growth factor. | Sci Rep | 2022 | 35440608 | PubTator, text mining | PubMed |
| Transcriptome analysis of skin color variation during and after overwintering of Malaysian red tilapia. | Fish Physiol Biochem | 2022 | 35419737 | PubTator, text mining | PubMed |
| Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice. | Sci Transl Med | 2022 | 35417192 | PubTator, text mining | PubMed |
| Degron-mediated proteolysis of CrhR-like DEAD-box RNA helicases in cyanobacteria. | J Biol Chem | 2022 | 35413287 | PubTator, text mining | PubMed |
| Identification, Isolation, and Characterization of Melanocyte Precursor Cells in the Human Limbal Stroma. | Int J Mol Sci | 2022 | 35409129 | PubTator, text mining | PubMed |
| Antioxidant Capacity of Potentilla paradoxa Nutt. and Its Beneficial Effects Related to Anti-Aging in HaCaT and B16F10 Cells. | Plants (Basel) | 2022 | 35406853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=34